Serum hepatitis B virus RNA is a predictor of HBeAg seroconversion and virological response with entecavir treatment in chronic hepatitis B patients

doi:10.3748/wjg.v25.i6.719

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 25, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7668)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

498

WORD

221

HTML

4371

Figures (1-3)

195

Tables (1-3)

166

Sum=5451

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

773

Download

1444

Sum=2217

Feb 14, 2019 (publication date) through Apr 19, 2024

Times Cited of This Article

Times Cited (15)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastroenterol. Feb 14, 2019; 25(6): 719-728
Published online Feb 14, 2019. doi: 10.3748/wjg.v25.i6.719

Table 1 Baseline characteristics of enrolled patients

Characteristic	Value
Gender (male/female)	25/5
Age (yr)	35.47 ± 11.05 (17-58)
Body mass index	24.40 ± 3.50 (18.64-32.27)
HBeAg+ (%)	25 (83%)
Alanine aminotransferase (IU/mL)	159.90 ± 226.70 (40-1308)
HBsAg (log₁₀ IU/mL)	3.97 ± 0.74 (2.29-4.88)
HBV DNA (log₁₀ IU/mL)	7.99 ± 1.32 (4.28-9.52)
HBV RNA (log₁₀ copies/mL)	4.15 ± 0.90 (2.24-5.66)
HBV genotype
B (%)	6 (20.00%)
C (%)	24 (80.00%)

HBV: Hepatitis B virus.

Citation: Luo H, Zhang XX, Cao LH, Tan N, Kang Q, Xi HL, Yu M, Xu XY. Serum hepatitis B virus RNA is a predictor of HBeAg seroconversion and virological response with entecavir treatment in chronic hepatitis B patients. World J Gastroenterol 2019; 25(6): 719-728
URL: https://www.wjgnet.com/1007-9327/full/v25/i6/719.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i6.719